G. U. Sultanmuratova, G. S. Babadjanova, J. B. Nazarbayev, N. M. Kerimova
(America, 2022-08)
The purpose of this study is to determine the safety of using of drospirenone-containing combined oral contraceptive (OC) in overweight/obese women of reproductive age.